Validation of warfarin pharmacogenetic algorithms in 586 Han Chinese patients

Author:

Peng Qi1,Huang Shujun2,Chen Xiaoying3,Yuan Yayan2,Yu Yajun2,Tao Liang1,Zhang Zhenlu4,Xu Mousheng2

Affiliation:

1. Cardiac Surgery, Wuhan Asia Heart Hospital, 753 Jinghan Ave, Jianghan District, Wuhan, Hubei, 430022, China

2. Hubei Vidagen Gene Technology Co., Ltd, Building C6-208, 666 Gaoxin Ave, Donghu High-Tech Developmental District, Wuhan, Hubei, 430075, China

3. Department of Cardiology, Wuhan Asia Heart Hospital, 753 Jinghan Ave, Jianghan District, Wuhan, Hubei, 430022, China

4. Clinical Test Center, Wuhan Asia Heart Hospital, 753 Jinghan Ave, Jianghan District, Wuhan, Hubei, 430022, China

Abstract

Aim: To compare the accuracy of the nine selected algorithms for predicting warfarin dose with 586 Han Chinese patients. Materials & methods: Genotyping of VKORC1 1639G>A, CYP2C9*2 and CYP2C9*3 variants was performed. Both the mean absolute error and ideal estimation value were used for comparison. Results: The top three performers were from East Asians. The algorithms from Caucasians generally performed better in the medium-dose subgroup (>3 and <7 mg/day), while the algorithms from East Asians generally performed better in the low-dose subgroup (≤3 mg/day). None of the algorithms performed well in the high-dose subgroup (≥7 mg/day). Conclusion: Algorithms built for specific ethnic groups and preassigned-dose groups are suggested for better prediction.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3